en

PRODUCT DETAIL

Arbicen 240 mg

Code 5170E
MA number 59/0275/23-S
Product Form: cps end 56x1x240 mg (blis.OPA/Al/PVC//Al - jednotk.bal.)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AX Other immunosuppressants
L04AX07 Dimethyl fumarate
Shelf life: 36
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 03.01.2024
Validity: 03.01.2029
Pediatric indication: Yes
Pediatric posology: Yes
Pediatric warnings: Yes
PIL: PIL_Arbicen_12_2023.pdf  
SPC: SPC_Arbicen_12_2023.pdf  
Safety feature Yes
Data update: 10.01.2024
eu-flag.png sk-flag.png